Tag: Aptar Pharma
Aptar Pharma opens new site near Mumbai
Aptar Pharma, a global name in drug delivery systems, services and active material science solutions, on 7 December announced the opening of its new...
Aptar Pharma’s multidose device delivers anti-CoV nasal spray
Aptar Pharma, a global leader in drug delivery systems, services, and active material science solutions, has announced that its VP7 nasal multidose device is...
Aptar Pharma completes US$180 million expansion program
Aptar Pharma, a global provider of drug delivery systems, services, and active material science solutions, has delivered the first phase of its previously announced...
Aptar Pharma gears up for CPhI Frankfurt 2022
Aptar Pharma will showcase its diverse portfolio of drug delivery systems, components, active packaging, and digital health solutions at the in-person CPhI Worldwide in...
Aptar Pharma acquires Metaphase Design Group
Aptar Pharma, a global leader in drug delivery and active material science solutions and services, announced that it has acquired Metaphase Design Group, a...
Aptar Pharma returns in-person to Pharmapack 2022
Aptar Pharma, in drug delivery and active material science solutions and services, is pleased to announce that it is an official premium partner at...
Voluntis and Tilak Healthcare partner to help cancer patients
Voluntis, an Aptar Pharma company and leader in digital therapeutics, announced a partnership with Tilak Healthcare, a digital therapeutics company specializing in clinically validated...
Drug delivery solutions provider Aptar to build a new facility in...
Drug delivery solutions provider Aptar Pharma recently announced the construction of a new facility in India at a ceremony also to celebrate Aptar Mumbai’s...
Aptar Pharma launches HeroTracker Sense
Aptar Pharma, a global enterprise in drug delivery systems, services, and active material science solutions, recently announced the launch of HeroTracker Sense, a novel...
Glenmark’s Ryaltris nasal spray receives approval from US FDA
Aptar Pharma has announced that its VP3 multidose device is the delivery system for Glenmark’s Ryaltris nasal spray, which recently received New Drug Application...